FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

JAKOBSEN HENNING I
2. Issuer Name and Ticker or Trading Symbol

COLGATE PALMOLIVE CO [ CL ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Financial Officer
(Last)          (First)          (Middle)

C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE
3. Date of Earliest Transaction (MM/DD/YYYY)

11/4/2020
(Street)

NEW YORK, NY 10022
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/4/2020  M(1)  39355.0000 A$61.9300 79756.0000 D  
Common Stock 11/4/2020  M(1)  35100.0000 A$72.9900 114856.0000 D  
Common Stock 11/4/2020  M(1)  33968.0000 A$73.0000 148824.0000 D  
Common Stock 11/4/2020  S(2)  145280.0000 D$85.2155 (3)3544.0000 D  
Common Stock         6797.0000 I By Issuer's 401(k) Plan Trustee 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy) $72.9900 11/4/2020  M (1)    35100.0000   (4)9/8/2022 Common Stock 35100.0000 $0.0000 0.0000 D  
Stock Option (Right to Buy) $61.9300 11/4/2020  M (1)    39355.0000   (5)9/10/2021 Common Stock 39355.0000 $0.0000 0.0000 D  
Stock Option (Right to Buy) $73.0000 11/4/2020  M (1)    33968.0000   (6)9/25/2023 Common Stock 33968.0000 $0.0000 0.0000 D  

Explanation of Responses:
(1) Exercise of stock options awarded under the issuer's incentive compensation plan.
(2) Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
(3) Weighted average price, as these shares were sold in multiple transactions at prices ranging from $84.94 to $85.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(4) Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2016 grant date.
(5) Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2015 grant date.
(6) Option became exercisable in one-third increments beginning on the first anniversary of the September 25, 2017 grant date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
JAKOBSEN HENNING I
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
NEW YORK, NY 10022


Chief Financial Officer

Signatures
/s/ Kristine Hutchinson, Attorney-in-Fact11/6/2020
**Signature of Reporting PersonDate

Colgate Palmolive (NYSE:CL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Colgate Palmolive Charts.
Colgate Palmolive (NYSE:CL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Colgate Palmolive Charts.